Unlock instant, AI-driven research and patent intelligence for your innovation.

Octapeptin as well as preparation and application thereof

A technology of peptides and preparations, applied in the field of new polymyxin analogs, can solve the problems of drug withdrawal and complicated treatment, and achieve the effect of good safety and obvious control effect

Inactive Publication Date: 2014-06-11
ZHEJIANG UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Although new evidence shows that the toxicity of polymyxin is not as serious as previously reported, its opportunistic toxicity, especially nephrotoxicity, often leads to treatment complications and even discontinuation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Octapeptin as well as preparation and application thereof
  • Octapeptin as well as preparation and application thereof
  • Octapeptin as well as preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Embodiment 1: Paenibacillus tianmuensis F6-B70 (CCTCC No: M 209149) is fermented according to the following conditions to produce a new compound of formula (I)

[0041] 1. Inoculate the strain F6-B70 on the slant of nutrient agar medium for activation, and culture at 30°C for 1-2 days;

[0042] 2. Put the slant seeds into 50mL seed culture medium in a 250mL Erlenmeyer flask, and culture at 30°C and 200rpm for 24 hours, which is the first-grade seed solution;

[0043] 3. Put the first-grade seed solution into 200mL seed medium in a 500mL Erlenmeyer flask, and shake and culture at 30°C and 200rpm for 24h to obtain the second-grade seed solution;

[0044] 4. The secondary seed solution was inserted into a 2L Erlenmeyer flask containing 500 mL of fermentation medium at an inoculum size of 5-10% (v / v), and cultured for 96 hours at 30° C. with shaking at 200 rpm to obtain a fermentation liquid.

[0045] Nutrient agar medium, prepared as follows: peptone 10g, beef extract 3g,...

Embodiment 2

[0048] Embodiment 2: the separation and purification of formula (I) novel compound

[0049] The fermentation broth obtained in Example 1 can be separated and purified according to the following steps to obtain the pure product of the new compound of formula (I) provided by the present invention.

[0050] 1. Transfer the fermentation broth to a centrifuge bottle, centrifuge at 6500×g for 30 minutes, remove the bacteria, and obtain a clarified fermentation supernatant;

[0051] 2. Pass the supernatant through the Amberlite XAD-16 chromatographic column balanced with water at a constant flow rate, and wash 5 to 10 samples with distilled water and aqueous solution containing 25% (v / v) methanol respectively after loading the samples Bed volume, and then eluted with an aqueous solution containing 80% (v / v) methanol, the elution peak eluted with 80% methanol aqueous solution was collected, concentrated and evaporated to dryness, and recorded as crude product 1.

[0052] 3. Dissolve ...

Embodiment 3

[0054] Embodiment 3: antibacterial activity assay

[0055] 1) Prepare the new compound of formula (I) with a concentration of 256 μg / ml with Mueller Hinton broth medium, and carry out two-fold dilution: the concentrations are respectively 256, 128, 64, 32, 16, 8, 4, 2, 1, 0.5 μg / ml.

[0056] 2) Add 50 μl of the new compound solution of formula (I) at different concentrations (200-0.39 μg / ml) after serial dilution to the 1st to 10th wells of the 96-well polystyrene plate, and add 50 μl Mueller Hinton broth medium (beef extract powder 2g / L, acid hydrolyzed casein 17.5g / L, starch 1.5g / L, solvent is water), as a growth control, add 100μl Mueller Hinton broth medium to the 12th well , as a negative control. Positive controls were polymyxin B and vancomycin.

[0057] 3) After culturing the indicator bacteria for 24 hours, dilute to 10 with Mueller Hinton broth medium 6 cells / ml, add 50 μl of diluted bacterial solution to the 1st to 11th wells, seal and incubate in an incubator a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a new octapeptin having biological control and medical treatment application potential values as well as a preparation method and an application thereof. The structure of the octapeptin is as shown in a formula (I). The new octapeptin provided by the invention has the beneficial effects that the octapeptin which has toxicity being less than that of polymyxin B and has medical treatment application value as well as the preparation method and application thereof are provided; an in vitro experiment indicates that the compound has obvious inhibition effects on tested Gran-negative bacteria; and an animal experiment indicates that the compound has a good treatment effect on a mouse septicemia model caused by Escherichia coli.

Description

(1) Technical field [0001] The invention relates to a novel polymyxin analogue-octopeptide and its preparation and application. (2) Background technology [0002] The emergence of pathogenic bacteria resistant to almost all antibiotics has made human health face an increasingly serious threat. While multidrug-resistant gram-positive and gram-negative bacteria are both a serious test of public health, the latter problem currently appears to be far greater. On the one hand, Gram-negative bacteria are becoming the main pathogenic bacteria for hospital and community infections, and the drug resistance of clinical isolates is increasing, especially Pseudomonas aeruginosa, Acinetobacter baumannii and Gram The important opportunistic pathogenic bacteria of Lebsiella infection in hospitals can easily mutate into super pathogenic bacteria resistant to almost all antibiotics, thus seriously affecting human health. According to reports, the rate of bacterial infection in intensive ca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/62C12P21/04C07K1/22A61K38/12A61P31/04C12R1/01
CPCY02A50/30
Inventor 吴雪昌钱朝东滕毅李欧赵文鹏
Owner ZHEJIANG UNIV